SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer

(MedPage Today) -- SAN DIEGO -- Stereotactic body radiation therapy (SBRT) was as effective as conventional radiation therapy (CRT) in treating intermediate-risk prostate cancer, according to results from the randomized PACE-B trial. Among 874...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news